...
When the Division of Biologics Standards (DBS) was transferred administratively from the National Institutes of Health (NIH) to the FDA in 1972, there were several organizational name changes. Biologics was renamed the Center for Biologics Evaluation and Research (CBER). Epstein has been the director , of the Office of Blood Research and Review at the FDA’s CBER since 1995.
...
Overview
Content Tools
ThemeBuilder